|
Tuesday, March 1 — 8:00 AM — Convention Center Room 007 A-D
Click on the numbers in parentheses to display abstracts.
Section D - GASTROINTESTINAL
Chaired by: Wendy L. Frankel and Stanley R. Hamilton
| 8:00 |
Site-Specific Ectopic Expression of Gastric Pyloric Mucin MUC6 in Colonic Hyperplastic Polyps and Serrated Adenomas
(452)
S Chiosea, SF Kuan - University of Pittsburgh, Pittsburgh, PA
|
| 8:15 |
Contrasting Patterns of Activating Mutations of RAS-RAF-MAP-Kinase Signaling Pathway and CpG Island Methylation Phenotype (CIMP) in Typical and Serrated Colorectal Adenomas
(562)
H Xu, S Yang, O Posnik, FA Farraye, CS Huang, C Mack, M Toomey, MJ O'Brien - Boston University School of Medicine, Boston, MA; Boston Medical Center, Boston, MA
|
| 8:30 |
BRAF Mutations in Hyperplastic Polyposis
(444)
RA Beach, TT Wu, A Chan, JA White, JS Morris, J Issa, SR Hamilton, A Rashid - University of Texas MD Anderson Cancer Center, Houston, TX
|
| 8:45 |
Low-Grade Tubuloglandular Adenocarcinoma Associated with Inflammatory Bowel Disease: A Study of 21 Cases
(498)
G Levi, N Harpaz - The Mount Sinai School of Medicine, New York, NY
|
| 9:00 |
Size and Number of Negative Lymph Nodes Impact Outcome in Patients with Node-Negative Stage II Colorectal Cancer
(453)
LR Chirieac, Y Suehiro, A Niemisto, I Shmulevich, S Lunagomez, JS Morris, SR Hamilton - UT M. D. Anderson Cancer Center, Houston, TX; Yamaguchi University School of Medicine, Ube, Yamaguchi, Japan; Institute of Signal Processing, Tampere, Finland; UT M. D. Anderson Cancer Center, Houston, TX
|
| 9:15 |
Impact of Bayes Theorem and Poisson Paradigm on Outcomes in Node Negative Colorectal Cancer Patients after Surgical Resection
(553)
JW Turner, RT Vollmer - Duke University Medical Center, Durham, NC; Durham VA Medical Center, Durham, NC
|
| 9:30 |
RECESS, EXHIBITS, POSTER SESSION III
|
| 11:00 |
Influence of Demographic and Specimen Related Parameters on EGFR Immunostaining in Colorectal Adenocarcinoma: A Study of 484 Cases
(551)
DO Treaba, CC Tse, LC Goldstein, PL Kandalaft, TS Barry, AM Gown - PhenoPath Laboratories and IMPRIS, Seattle, WA
|
| 11:15 |
Immunohistochemical Staining for MLH1, MSH2 and MSH6 Identifies Germline Mutations in Mismatch Repair Genes in Colorectal and Endometrial Cancers Initially Found To Be Microsatellite Stable
(467)
WL Frankel, H Hampel, J LaJeunesse, J Panescu, S Jones, A de la Chapelle - Ohio State University, Columbus, OH
|
| 11:30 |
Family History of Sporadic Colorectal Cancer Modifies Risks for Specific Molecular Pathology in Tumors: Data from Prospective Cohort of 86,220 Women
(519)
S Ogino, G Kirkner, M Cantor, M Brahmandam, T Kawasaki, C Namgyal, EL Giovannucci, M Loda, CS Fuchs - Brigham and Women's Hospital, Boston, MA; Dana-Farber Cancer Institute, Boston, MA; Harvard Medical School, Boston, MA; Harvard School of Public Health, Boston, MA
|
| 11:45 |
Claudin-1 Is a Strong Prognostic Indicator in Stage II Colonic Cancer: A Tissue Microarray Study
(530)
MB Resnick, T Konkin, E Sabo, VE Pricolo - Rhode Island Hospital, Providence, RI
|
|
|
